Cardiovascular (CV) disease (CVD) accounts for> 50% of deaths with known causes in
patients on dialysis. Elevated serum phosphorus levels are an important nontraditional risk …

Objectives This review summarizes factors relevant for adherence to phosphate-control
strategies in dialysis patients, and discusses interventions to overcome related challenges …

Management of hyperphosphatemia in patients with dialysis-dependent chronic kidney
disease remains a major challenge, requiring a multifaceted approach that includes dietary …

Background Uncontrolled hyperphosphatemia in chronic kidney disease (CKD) patients
commonly results in vascular calcification leading to increased risk of cardiovascular …

As kidney disease progresses, phosphorus retention also increases, and phosphate binders
are used to treat hyperphosphatemia. Clinicians prescribe phosphate binders thinking that …

Medicare costs for phosphate binders for US dialysis patients and patients with chronic
kidney disease enrolled in Medicare Part D exceeded $1.5 billion in 2015. Previous data …

Intradialytic exercise (IDE) is not routinely prescribed in hemodialysis (HD) units despite its
potential benefits on patients' outcomes. This study was the first in the United Arab Emirates …

Background: The efficacy of cuttlebone for treating hyperphosphatemia in patients with end-
stage renal disease and its safety remained unclear. Methods: Randomized controlled trials …

Aim: To assess the cost-effectiveness of nutrition education by dedicated dietitians (DD) for
hyperphosphatemia management among hemodialysis patients. Materials and methods …

Abstract Background The Nutrition Education for Management of Osteodystrophy trial
showed that stage‐based nutrition education by dedicated dietitians surpasses existing …